Vasopressin in Traumatic Hemorrhagic Shock Study

NCT00379522 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Shock
Hypovolemia
Hemorrhagic Shock

Interventions

DRUG: Vasopressin
DRUG: Saline placebo

Sponsor

Volker Wenzel